Taninder Kaur Tharani
Child & Adolescent Psychiatry · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Taninder Kaur Tharani’s office at (408) 284-9000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A109480 · Current
Licensed to practise in California · since 2009 · expires 2026-12-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 20 Part D prescriptions in 2017. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2017 | 20 | None | 0% (0) | None | $245 |
| 2014 | 14 | None | 0% (0) | 100% | $13,289 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2014: 1 drug
| Invega Sustenna | 14 | $13,289 | $949 |
Money from drug and device companies
$360 in 2025
| 2025 | 2 | 3 | None | $360 |
| 2024 | 4 | 5 | None | $586 |
| 2023 | 1 | 2 | None | $235 |
| 2022 | 2 | 3 | None | $341 |
| 2021 | 1 | 2 | None | $249 |
| 2020 | 1 | 1 | None | $19 |
| 2019 | 4 | 8 | None | $769 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Invega Sustenna | $253 | 2 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $106 | 1 payment
|
See all 3 published payments
| Janssen Pharmaceuticals | Meals · 2025-07-31 | Invega Sustenna | $104 |
| Janssen Pharmaceuticals | Meals · 2025-06-18 | Invega Sustenna | $149 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-20 | Caplyta | $106 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $586
| Alkermes | Lybalvi | $237 | 2 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $129 | 1 payment
|
| Vanda Pharmaceuticals | Fanapt | $125 | 1 payment
|
| Neuronetics | Neurostar Tms Therapy System | $95 | 1 payment
|
2023: $235
| Alkermes | Aristada | $235 | 2 payments
|
2022: $341
| Alkermes | Lybalvi | $221 | 2 payments
|
| Neuronetics | Neurostar Tms Therapy System | $120 | 1 payment
|
2021: $249
| Alkermes | Aristada | $249 | 2 payments
|
2020: $19
| Alkermes | Aristada | $19 | 1 payment
|
2019: $769
| Alkermes | Aristada | $269 | 3 payments
|
| Sunovion Pharmaceuticals | Latuda | $247 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $127 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $125 | 1 payment
|
Professional record
- NPI
- 1013244235
- Licence
- CA A109480California A109480: Current · expires 2026-12-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0804X (2084P0804X); Psychiatry (2084P0800X)
- Mailing address
- 1885 Lundy Ave Ste 223, San Jose, CA, 95131
- NPI first listed
- 2009-11-09
- NPI last updated
- 2023-06-28
- NPI record certified
- 2023-06-28
This is when the NPI record was last certified, not a medical board exam.